XML 71 R74.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Equity Transactions - Stock Appreciation Rights Activity (Details) - Stock appreciation rights - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Sep. 30, 2019
Sep. 30, 2018
SARs    
Outstanding as of September 30, 2018 (in shares) 934,205  
Granted (in shares) 95,000  
Exercised (in shares) (181,009)  
Forfeited (in shares) (414,614)  
Outstanding as of September 30, 2019 (in shares) 433,582 934,205
Vested and expected to vest as of September 30, 2019 (in shares) 379,179  
Exercisable as of September 30, 2019 (in shares) 143,375  
Weighted- Average Exercise Price    
Outstanding as of September 30, 2018 (in dollars per share) $ 7.23  
Granted (in dollars per share) 6.11  
Exercised (in dollars per share) 4.57  
Forfeited (in dollars per share) 8.90  
Outstanding as of September 30, 2019 (in dollars per share) 6.49 $ 7.23
Vested and expected to vest as of September 30, 2019 (in dollars per share) 5.95  
Exercisable as of September 30, 2019 (in dollars per share) $ 5.83  
Weighted- Average Remaining Contractual Term (years)    
Outstanding, weighted-average remaining contractual term 11 months 4 days 9 months 10 days
Vested and expected to vest as of September 30, 2019, weighted-average remaining contractual term 11 months 1 day  
Exercisable as of September 30, 2019, weighted average remaining contractual term 2 months 23 days  
Aggregate Intrinsic Value    
Outstanding as of September 30, 2018, aggregate intrinsic value $ 789  
Granted, aggregate intrinsic value 0  
Exercised, aggregate intrinsic value 491  
Forfeited, aggregate intrinsic value 74  
Outstanding as of September 30, 2019, aggregate intrinsic value 748 $ 789
Vested and expected to vest as of September 30, 2019, aggregate intrinsic value 748  
Exercisable as of September 30, 2019, aggregate intrinsic value $ 316